VBL Therapeutics to Present at 29th Annual J.P. Morgan Healthcare Conference
1/4/2011 8:53:09 AM
(BUSINESS WIRE)--VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that Dror Harats, M.D., chief executive officer, will present at the 29th Annual J.P. Morgan Healthcare Conference. Dr. Harats’ presentation is scheduled to begin at 11:30 a.m. PST on Tuesday, Jan. 11, 2011 at the Westin St. Francis Hotel in San Francisco.
comments powered by